| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |